NCT05613140View on ClinicalTrials.gov

Sacubitril/Valsartan Treated Adult Patients With Chronic Heart Failure

CompletedOBSERVATIONAL
Enrollment

9,230

Participants

Timeline

Start Date

August 2, 2021

Primary Completion Date

November 5, 2021

Study Completion Date

November 5, 2021

Conditions
Chronic Heart Failure
Interventions
DRUG

sacubitril/valsartan

Two study cohorts were constructed to include adult HFrEF patients who newly initiated sacubitril/valsartan (Cohort 1) and adult CHF patients who newly initiated sacubitril/valsartan (Cohort 2).

Trial Locations (1)

07936-1080

Novartis Investigative Site, East Hanover

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY